checkAd

     224  0 Kommentare Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering - Seite 3

    Contacts

    Investors:
    Monique Kosse
    Managing Director
    LifeSci Advisors
    646-915-3820
    monique@lifesciadvisors.com

    Lesen Sie auch

     



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Cellectar Biosciences Announces Closing of $20 Million Underwritten Public Offering - Seite 3 FLORHAM PARK, N.J., June 05, 2020 (GLOBE NEWSWIRE) - Cellectar Biosciences (Nasdaq: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced …